Michael Poulsen

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

James W. Denham, Allison Steigler, David S. Lamb et al. · The Lancet Oncology · 2005 · 377 citations

Medicine, Oncology, Radiation Oncology +15

Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)

Danny Rischin, Lester Peters, Richard Fisher et al. · Journal of Clinical Oncology · 2004 · 250 citations

Medicine, Oncology, Chemotherapy +7

Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma

Peter C. O’Brien, Daniel Roos, Gary Pratt et al. · Journal of Clinical Oncology · 2000 · 237 citations

Medicine, Oncology, Chemotherapy +12

High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study—TROG 96:07

Michael Poulsen, Danny Rischin, Euan Walpole et al. · Journal of Clinical Oncology · 2003 · 211 citations

Medicine, Oncology, Radiation Oncology +16

Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy

Sandro Porceddu, David Pryor, Elizabeth Burmeister et al. · Head & Neck · 2011 · 173 citations

Medicine, Nuclear Medicine, Oncology +16